Header Logo

Prarthna Bhardwaj

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
8
2025
1118
3.830
Why?
Receptor, ErbB-2
2
2024
51
1.840
Why?
Molecular Targeted Therapy
2
2024
121
1.100
Why?
Pregnancy Complications, Neoplastic
1
2025
11
0.960
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2024
406
0.910
Why?
Breast Neoplasms, Male
1
2024
14
0.890
Why?
Receptors, Estrogen
1
2024
124
0.880
Why?
Immunoconjugates
1
2023
85
0.840
Why?
Triple Negative Breast Neoplasms
1
2023
59
0.820
Why?
BRCA2 Protein
1
2022
13
0.810
Why?
Febrile Neutropenia
1
2021
4
0.730
Why?
Frail Elderly
1
2021
107
0.690
Why?
Capecitabine
1
2019
10
0.660
Why?
Antineoplastic Agents
2
2025
631
0.660
Why?
Antimetabolites, Antineoplastic
1
2019
39
0.640
Why?
Frailty
1
2021
124
0.620
Why?
Takotsubo Cardiomyopathy
1
2019
64
0.610
Why?
Body Mass Index
1
2021
831
0.560
Why?
Female
11
2025
30705
0.490
Why?
Hospitalization
1
2021
1290
0.440
Why?
Humans
12
2025
59360
0.360
Why?
Neoplasms
1
2021
1240
0.360
Why?
Prospective Studies
2
2024
3067
0.240
Why?
Antineoplastic Agents, Hormonal
1
2024
30
0.230
Why?
Receptors, Progesterone
1
2024
108
0.220
Why?
Neoplasm Metastasis
1
2024
188
0.220
Why?
Survivorship
1
2024
12
0.220
Why?
Mastectomy
1
2024
52
0.220
Why?
Chemotherapy, Adjuvant
1
2023
75
0.210
Why?
India
1
2023
150
0.200
Why?
Disease Management
1
2024
221
0.200
Why?
Neoadjuvant Therapy
1
2023
72
0.200
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2022
19
0.200
Why?
Treatment Outcome
2
2024
5284
0.200
Why?
BRCA1 Protein
1
2022
54
0.190
Why?
Hemophilia A
1
2022
56
0.190
Why?
Germ Cells
1
2022
97
0.190
Why?
Genetic Testing
1
2022
126
0.190
Why?
Clinical Trials as Topic
1
2024
441
0.190
Why?
Antibodies, Bispecific
1
2022
29
0.190
Why?
Biomarkers, Tumor
1
2024
461
0.180
Why?
Mammography
1
2024
269
0.180
Why?
Aged, 80 and over
2
2021
5128
0.170
Why?
Patient Care Team
1
2023
326
0.170
Why?
Retrospective Studies
2
2023
6071
0.170
Why?
Early Detection of Cancer
1
2023
266
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2022
219
0.170
Why?
Anus Neoplasms
1
2019
23
0.160
Why?
Chest Pain
1
2019
81
0.150
Why?
Middle Aged
3
2024
16317
0.150
Why?
Algorithms
1
2023
976
0.150
Why?
Inpatients
1
2021
291
0.150
Why?
Health Knowledge, Attitudes, Practice
1
2023
724
0.150
Why?
Predictive Value of Tests
1
2021
1025
0.150
Why?
Pregnancy
1
2025
2202
0.150
Why?
Cardiac Catheterization
1
2019
252
0.140
Why?
Cohort Studies
1
2021
2374
0.120
Why?
HIV Infections
1
2022
913
0.120
Why?
Cross-Sectional Studies
1
2021
2373
0.110
Why?
Risk Assessment
1
2021
1921
0.110
Why?
Male
2
2024
27739
0.100
Why?
Aged
1
2021
13416
0.060
Why?
Factor VIII
1
2022
31
0.050
Why?
Bhardwaj's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_